Last verified: March 31, 2026 · Sources: Eli Lilly,¹ FDA,² Reuters³ · Our methodology

Availability Tracker · Updated March 31, 2026

Orforglipron Availability (March 2026): Is It Available Yet?

No — orforglipron is not available to the public as of March 31, 2026. But this is about to change. Lilly's official guidance says potential U.S. action for obesity is expected in Q2 2026, and Reuters has separately reported an April 10, 2026 target action date.¹ ³ If approved, Eli Lilly says self-pay pricing through LillyDirect would start at $149/month, and the company has said it can begin shipping within about a week of approval.³

If you've been searching for orforglipron availability, here's the full picture — current status, the timeline backed by sources you can check yourself, the pricing paths Lilly has publicly disclosed, how to avoid scams, and an honest breakdown of whether waiting makes sense for your situation. We verified every major claim on this page and linked the sources below.

Orforglipron Availability Snapshot

Every row verified March 31, 2026. We update within 24 hours of any FDA action or Lilly announcement. Next watch date: April 10, 2026.

Is Orforglipron Available Right Now?

No, and it won't be until the FDA makes its decision.

Eli Lilly's official FAQ says it plainly: “Orforglipron is still in development, and not available to the public.”¹ That means it is not FDA-approved, not at retail pharmacies, not available through telehealth, and not legitimately sold through any online channel.

No U.S. state has public commercial access. If someone is selling you “orforglipron” today, they are not selling you orforglipron. But if you're already thinking “I don't want to just wait around” — we cover that in the decision section below. You have options right now.

When Will Orforglipron Be Available?

The answer has gotten much sharper in the last few months.

Key Timeline Milestones

Important framing: Treat the reported April 10 date as the best current reported target, not a guarantee. The FDA doesn't publicly confirm target action dates for drugs under review. But the combination of the CNPV expedited pathway, four positive Phase 3 trials, and Lilly's aggressive manufacturing preparation makes this one of the most anticipated approvals of 2026.

Is April 10 the Official FDA Decision Date?

This nuance matters and we want to get it right.

April 10, 2026 is the target action date reported by Reuters, citing internal regulatory documents.³ It is not a date Eli Lilly has publicly confirmed — their official language remains “potential U.S. action for obesity in Q2 2026.”¹ The FDA does not publicly announce target dates for drugs under review.

Reuters later clarified its reporting to say the FDA decision is expected in the early second quarter, which aligns with the April timeframe but leaves room for the exact date to shift.⁴

How Much Will Orforglipron Cost?

Price is the second-biggest question after “when” — and the news is better than most people expect. In November 2025, Eli Lilly announced a government agreement to expand access to its obesity medicines. The deal included specific pricing commitments for orforglipron if it receives FDA approval.⁵

Verified Orforglipron Pricing Paths

Note: The Lilly government agreement specifically states that the commercial channel is not included in these pricing obligations.⁵ Commercial copay estimates from other sources are speculative until orforglipron is approved and on formulary.

Why This Pricing Is Noteworthy

Orforglipron is a small-molecule drug, not a peptide. That makes it fundamentally cheaper to manufacture than injectable GLP-1s — no cold storage, no complex biologic production, no injection devices. Lilly's CEO has said publicly that the lower manufacturing complexity could translate to better affordability.

Here's how orforglipron's disclosed pricing compares to what's available today:

Should You Wait for Orforglipron or Start an Oral GLP-1 Now?

This is the real decision. And it deserves an honest answer, not a redirect. The Wegovy pill (oral semaglutide) was approved in December 2025 and is available at pharmacies across the U.S. right now.⁷ It works. Orforglipron could be approved within weeks — but “could be” isn't “is.”

Decision Framework

If You Don't Want to Wait: The Current Path

You can read our full Orforglipron vs. Wegovy Pill comparison for the deep breakdown. But here's the short version.

The Wegovy Pill — Available Today

The Wegovy pill was FDA-approved in December 2025 and is available at pharmacies nationwide.⁷ The highest-dose oral semaglutide has shown weight loss in the range of 14–17% in clinical trials — putting it in striking distance of the injectable versions.

The catch: You need to take it first thing in the morning on an empty stomach with a small amount of water, then wait 30 minutes before eating, drinking, or taking other medications.⁷ For some people, that's manageable. For others, it's a dealbreaker.

Current self-pay pricing: $149/month for 1.5mg and 4mg doses (through August 31, 2026). Higher doses (9mg, 25mg) are $299/month.⁷

Here's something worth knowing: Lilly's own ATTAIN-MAINTAIN trial data supports switching from injectable Wegovy or Zepbound to orforglipron while maintaining most of the weight loss you've already achieved.⁹ That means starting now and transitioning later isn't settling — it's a strategy backed by Phase 3 data. You don't have to choose one path forever.

Every month you spend deciding is a month of progress you could be making. Read our full Orforglipron vs. Wegovy Pill breakdown →

Why Everyone's Watching Orforglipron

What Do the Clinical Trial Results Show?

Here are the numbers. No spin.

How Does This Stack Up?

*Based on higher-dose clinical trial data for oral semaglutide.

Losing 12% of your body weight is meaningful — for someone starting at 250 lbs, that's 30 pounds. Where orforglipron wins is the convenience equation: daily pill, no fasting, no needles, no refrigeration.

What Are the Side Effects?

No honest availability page skips this. Here's what the trial data shows. In Phase 3 trials, Lilly says orforglipron's safety profile was consistent with the GLP-1 class, with gastrointestinal side effects most commonly reported.¹⁰ ¹¹ Final U.S. warning language will depend on the approved label.

Practical takeaway: The GI side effects are somewhat more frequent than oral semaglutide, but they typically improve during the dose titration period when you start low and increase gradually. If you've tolerated a GLP-1 before, you'll likely tolerate orforglipron. If you haven't, expect an adjustment period — it's normal with this entire drug class.

Is Orforglipron the Right GLP-1 for You?

How to Prepare for Orforglipron Launch Day

If you've decided to wait, here's a checklist that could save you weeks of frustration once the FDA acts.

Before the FDA decision (do this now):

1. 1Talk to your doctor. Ask if they'd be willing to prescribe orforglipron once available. Having that conversation now means you're not starting from scratch on launch day.
2. 2Check your insurance. Call member services and ask: “Do you cover GLP-1 medications for weight loss?” and “What’s your prior authorization process?” If they cover Mounjaro or Zepbound, orforglipron may eventually get similar treatment.
3. 3Get familiar with LillyDirect. It's expected to be the first access channel. Create an account so you're ready.
4. 4Document your health conditions. Prior authorization typically requires BMI documentation, weight-related comorbidities, and evidence that lifestyle interventions alone haven't been sufficient. Having recent labs ready speeds up the process.
5. 5Know your pricing path. $149–$399 self-pay via LillyDirect. $50/month for qualifying Medicare beneficiaries. Commercial insurance: TBD. Knowing your path before launch day eliminates one more point of friction.

After FDA approval (if it happens):

1. 6Contact your doctor immediately to request a prescription.
2. 7Check LillyDirect first — it's expected to be the fastest route.
3. 8If using insurance, expect a formulary delay. Self-pay through LillyDirect may be faster while insurance catches up.
4. 9Start at the lowest dose. Orforglipron uses dose titration — you start low and increase over weeks to minimize side effects.

Frequently Asked Questions

What Happens Next

You're not behind. You're right on time.